S. 705 · Senate · Introduced Feb 25, 2025

Innovation in Pediatric Drugs Act of 2025

Sponsored by Jack Reed (D, RI)

  1. INTRODUCED
  2. COMMITTEE
    Feb 25, 2025
  3. PASSED SENATE
  4. HOUSE
  5. LAW

In committee. Latest action on Feb 25, 2025: Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1347). It has 1 cosponsors and 2 recorded actions, and 4 organizations cited it in Q2 2026 lobbying disclosures.

Recent actions

2 total
Feb 25, 2025 · Library of Congress

Introduced in Senate

Feb 25, 2025 · Senate

Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S1347)

Reported lobbying

4
organizations cited S. 705 in a lobbying disclosure
Q2 2026 · the most recent completed reporting period you can see
OrganizationFiled byTotal Q2 2026 lobbying
Biotechnology Innovation OrganizationIn-house$2,360,000
Association for Clinical Oncology (ASCO)In-house$480,000
National Association of Pediatric Nurse PractitionersMason Consulting$24,000
Children's Cause For CancerI Street Advocates$10,000

These totals are not spending on this bill. Lobbying is reported per filing, not per issue — each figure is everything the organization reported for the period, across every bill and agency it named. Read it as scale of presence.

Latest activity

July 2026
Lobbying reported · Mason Consulting · Jul 22
Mason Consulting reported 2nd Quarter (Apr 1 - June 30) lobbying for National Association of Pediatric Nurse Practitioners — $24,000
You’re all caught up.